Literature DB >> 3338369

Acid-induced esophagitis in cats is prevented by sucralfate but not synthetic prostaglandin E.

P O Katz1, K R Geisinger, M Hassan, W C Wu, D Huang, D O Castell.   

Abstract

The cytoprotective effects of liquid sucralfate and a synthetic analog of prostaglandin E1 (PGE1) on acid-induced esophagitis in cats were studied. Esophagitis was induced in adult cats using a constant infusion of 0.1 N HCl at 1 ml/min for 20 min. Animals were infused for either one or three days. Mucosal lesions were evaluated by blinded investigators using both fiberoptic endoscopy and light microscopy. Histologic changes included basal cell hyperplasia, intraepithelial leukocytosis, and subepithelial leukocytosis. Liquid sucralfate given prior to acid infusion consistently prevented acid-induced lesions in both one- and three-day infusions, demonstrated by both endoscopy and quantitative histologic scoring. Indomethacin (200 micrograms/kg) given prior to sucralfate and acid did not affect sucralfate cytoprotection. Synthetic PGE1, given in doses of 5 micrograms/kg and 100 micrograms/kg, afforded no esophageal cytoprotection. These studies indicate that sucralfate is cytoprotective against acid-induced esophageal injury in cats, an effect that does not appear to be mediated by prostaglandin. In addition, synthetic PGE1 does not confer protection in this animal model.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3338369     DOI: 10.1007/bf01535736

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  14 in total

1.  Cytoprotection by prostaglandins.

Authors:  A Robert
Journal:  Gastroenterology       Date:  1979-10       Impact factor: 22.682

2.  Beneficial effect of indomethacin on acid-induced esophagitis in cats.

Authors:  G L Eastwood; B D Beck; D O Castell; F C Brown; J R Fletcher
Journal:  Dig Dis Sci       Date:  1981-07       Impact factor: 3.199

3.  Effects of an antiulcer drug, sucralfate (a basic aluminum salt of sulfated disaccharide), on experimental gastric lesions and gastric secretion in rats.

Authors:  S Okabe; K Takeuchi; H Kunimi; M Kanno; M Kawashima
Journal:  Dig Dis Sci       Date:  1983-11       Impact factor: 3.199

4.  Early vascular injury and increased vascular permeability in gastric mucosal injury caused by ethanol in the rat.

Authors:  S Szabo; J S Trier; A Brown; J Schnoor
Journal:  Gastroenterology       Date:  1985-01       Impact factor: 22.682

5.  Radiation esophagitis in the opossum: radioprotection with indomethacin.

Authors:  M G Northway; H I Libshitz; B M Osborne; M S Feldman; J J Mamel; J H West; I A Szwarc
Journal:  Gastroenterology       Date:  1980-05       Impact factor: 22.682

6.  Efficacy of sucralfate for duodenal ulcers: a multicenter, double-blind trial.

Authors:  D Hollander
Journal:  J Clin Gastroenterol       Date:  1981       Impact factor: 3.062

7.  Does sucralfate affect the normal gastric mucosa? Histologic, ultrastructural, and functional assessment in the rat.

Authors:  A Tarnawski; D Hollander; W J Krause; R D Zipser; J Stachura; H Gergely
Journal:  Gastroenterology       Date:  1986-04       Impact factor: 22.682

8.  Misoprostol in the treatment of duodenal ulcer. A multicenter double-blind placebo-controlled study.

Authors:  S J Sontag; P A Mazure; J F Pontes; S G Beker; E Z Dajani
Journal:  Dig Dis Sci       Date:  1985-11       Impact factor: 3.199

9.  Sucralfate prevents experimental peptic esophagitis in rabbits.

Authors:  E J Schweitzer; B L Bass; L F Johnson; J W Harmon
Journal:  Gastroenterology       Date:  1985-03       Impact factor: 22.682

10.  Antacid versus sucralfate in preventing acute gastrointestinal bleeding. A randomized trial in 100 critically ill patients.

Authors:  E Borrero; I B Margolis; S Bank; N Shulman; R Chardavoyne
Journal:  Am J Surg       Date:  1984-12       Impact factor: 2.565

View more
  3 in total

1.  Continuous versus intermittent acid exposure in production of esophagitis in feline model.

Authors:  K T Cassidy; K R Geisinger; B B Kraus; D O Castell
Journal:  Dig Dis Sci       Date:  1992-08       Impact factor: 3.199

Review 2.  Inflammatory mediators in the oesophagus.

Authors:  G P Morgan; J G Williams
Journal:  Gut       Date:  1994-03       Impact factor: 23.059

Review 3.  Medical treatment of esophageal motility disorders.

Authors:  H D Allescher; W J Ravich
Journal:  Dysphagia       Date:  1993       Impact factor: 3.438

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.